Abalos Therapeutics Appoints Gerben Moolhuizen As CEO
09 Oct 2024 //
BUSINESSWIRE
Abalos Therapeutics Appoints Thomas Bogenrieder as CMO
19 Oct 2022 //
MEDICALBUYER
Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
18 Oct 2022 //
BUSINESSWIRE
Abalos with unique approach makes investors reach deeper into their wallets
14 Oct 2021 //
ENDPTS
Abalos Completes Series A Extension Bringing Total Raised to EUR 43M
14 Oct 2021 //
BUSINESSWIRE
Abalos Therapeutics Expands Leadership Team with Drug Development
05 Feb 2020 //
BUSINESSWIRE
Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
15 Oct 2019 //
BUSINESSWIRE